BE861306A - Nouveaux derives de la cephalosporine a large spectre d'activite antibiotique - Google Patents
Nouveaux derives de la cephalosporine a large spectre d'activite antibiotiqueInfo
- Publication number
- BE861306A BE861306A BE183016A BE183016A BE861306A BE 861306 A BE861306 A BE 861306A BE 183016 A BE183016 A BE 183016A BE 183016 A BE183016 A BE 183016A BE 861306 A BE861306 A BE 861306A
- Authority
- BE
- Belgium
- Prior art keywords
- wide spectrum
- antibiotic activity
- cephalosporin derivatives
- new cephalosporin
- new
- Prior art date
Links
- 229930186147 Cephalosporin Natural products 0.000 title 1
- 230000003115 biocidal effect Effects 0.000 title 1
- 229940124587 cephalosporin Drugs 0.000 title 1
- 150000001780 cephalosporins Chemical class 0.000 title 1
- 238000001228 spectrum Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/58—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with a nitrogen atom, which is a member of a hetero ring, attached in position 7
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB49962/76A GB1596278A (en) | 1976-11-30 | 1976-11-30 | 7-(-oxyimino-acetamino)cephalosporin derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE861306A true BE861306A (fr) | 1978-05-29 |
Family
ID=10454140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE183016A BE861306A (fr) | 1976-11-30 | 1977-11-29 | Nouveaux derives de la cephalosporine a large spectre d'activite antibiotique |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4385177A (fr) |
| JP (1) | JPS5387392A (fr) |
| AU (1) | AU521575B2 (fr) |
| BE (1) | BE861306A (fr) |
| CH (1) | CH637139A5 (fr) |
| DE (1) | DE2753182A1 (fr) |
| DK (1) | DK528777A (fr) |
| FR (1) | FR2373547A1 (fr) |
| GB (1) | GB1596278A (fr) |
| NL (1) | NL7713135A (fr) |
| SE (1) | SE7713521L (fr) |
| ZA (1) | ZA777087B (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7805715A (nl) * | 1977-06-03 | 1978-12-05 | Hoffmann La Roche | Werkwijze voor het bereiden van acylderivaten. |
| US4252802A (en) * | 1980-03-13 | 1981-02-24 | E. R. Squibb & Sons, Inc. | Hydroxamic acid derivatives of 7-[(2-amino-4-thiazolyl)-oximino] cephalosporins |
| US4647660A (en) * | 1985-05-02 | 1987-03-03 | E. R. Squibb & Sons, Inc. | 3-acylamino-2-oxo-1-azetidinesulfonic acids |
| EP0303172A3 (fr) * | 1987-08-14 | 1991-05-15 | F. Hoffmann-La Roche Ag | Oxyimino-céphalosporines |
| EP0336667A3 (fr) * | 1988-04-04 | 1991-04-10 | E.R. Squibb & Sons, Inc. | Sulfate de [3S(Z)]-3-[[(2-amino-4-thiazolyl)[[2-(hydroxyamino)-2-oxoéthoxy]imino]acétyl]-amino]-2,2-diméthyl-4-oxo-1-azétidine |
| KR0178011B1 (ko) * | 1990-08-02 | 1999-03-20 | 이시하시 마까오 | 신규 세팔로스포린계 화합물 |
| AR003509A1 (es) * | 1995-09-15 | 1998-08-05 | Merck & Co Inc | Sintesis de alfa-cloro o fluoro cetonas. |
| US5786515A (en) * | 1995-09-15 | 1998-07-28 | Merck & Co., Inc. | Synthesis of α-chloro or fluoro ketones |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4064346A (en) * | 1971-05-14 | 1977-12-20 | Glaxo Laboratories Limited | 3-Acetoxymethyl-7β-(2-carboxy-methoxyimino-2-arylacetamido)ceph-3-em-4-carboxylic acids and salts thereof |
| US3944546A (en) * | 1972-08-04 | 1976-03-16 | E. R. Squibb & Sons, Inc. | Cyanomethylthioacetylcephalosporins |
| US4144393A (en) * | 1973-12-21 | 1979-03-13 | Glaxo Laboratories Limited | 3-Acetoxymethyl cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyiminoarylacetamido group |
| DK674674A (fr) | 1973-12-21 | 1975-09-08 | Glaxo Lab Ltd | |
| GB1555471A (en) * | 1975-06-19 | 1979-11-14 | Glaxo Lab Ltd | 7 carbamoylalkoxyimino acetamido 3 em 4 carboxylic acidsand derivatives thereof |
-
1976
- 1976-11-30 GB GB49962/76A patent/GB1596278A/en not_active Expired
-
1977
- 1977-11-29 BE BE183016A patent/BE861306A/fr not_active IP Right Cessation
- 1977-11-29 DK DK528777A patent/DK528777A/da not_active Application Discontinuation
- 1977-11-29 JP JP14378477A patent/JPS5387392A/ja active Pending
- 1977-11-29 AU AU31037/77A patent/AU521575B2/en not_active Expired
- 1977-11-29 NL NL7713135A patent/NL7713135A/xx not_active Application Discontinuation
- 1977-11-29 DE DE19772753182 patent/DE2753182A1/de not_active Withdrawn
- 1977-11-29 ZA ZA00777087A patent/ZA777087B/xx unknown
- 1977-11-29 SE SE7713521A patent/SE7713521L/xx not_active Application Discontinuation
- 1977-11-29 CH CH1467177A patent/CH637139A5/de not_active IP Right Cessation
- 1977-11-30 FR FR7736154A patent/FR2373547A1/fr active Granted
-
1980
- 1980-02-25 US US06/124,109 patent/US4385177A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DK528777A (da) | 1978-05-31 |
| GB1596278A (en) | 1981-08-26 |
| SE7713521L (sv) | 1978-07-20 |
| FR2373547B1 (fr) | 1983-01-21 |
| CH637139A5 (de) | 1983-07-15 |
| FR2373547A1 (fr) | 1978-07-07 |
| ZA777087B (en) | 1978-09-27 |
| NL7713135A (nl) | 1978-06-01 |
| AU3103777A (en) | 1979-06-07 |
| AU521575B2 (en) | 1982-04-22 |
| US4385177A (en) | 1983-05-24 |
| JPS5387392A (en) | 1978-08-01 |
| DE2753182A1 (de) | 1978-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE865163A (fr) | Nouveaux derives de la taurine a activite neuro-musculaire renforcee | |
| BE888895A (fr) | Nouveaux derives d'imidazo-rifamycine a activite antibacterienne | |
| MC1220A1 (fr) | Nouveaux derives d'imidazolidine | |
| BE868532A (fr) | Nouveaux derives de la thiazolidine | |
| BE857519A (fr) | Nouveaux derives d'acides azolyl-carboxyliques | |
| BE852141A (fr) | Nouveaux derives de sulfonamide | |
| FR2348926A1 (fr) | Nouveaux derives de l'adenine | |
| BE861306A (fr) | Nouveaux derives de la cephalosporine a large spectre d'activite antibiotique | |
| FR2348182A1 (fr) | Nouveaux derives d'acides m-phenyl-phenoxy-propioniques | |
| LU80669A1 (fr) | Nouveaux antibiotiques de cephalosporine a large spectre | |
| BE856695A (fr) | Derives de peptides a activite biologique | |
| BE850492A (fr) | Nouveaux derives de la piperazine | |
| BE853578A (fr) | Derives de thiouree | |
| BE851443A (fr) | Nouveaux derives de la piperazine | |
| BE858344A (fr) | Nouveaux derives encephaloniques a la methionine | |
| BE856975A (fr) | Nouveaux derives d'acides phenoxyphenoxy-alcanecarboxyliques | |
| BE859439A (fr) | Nouveaux derives de piperazine | |
| BE859567A (fr) | Derives piperidylideniques de benzo-xanthenes | |
| BE863074A (fr) | Nouveaux derives de cycloalcanecarbosanilide a activite herbicide | |
| BE861305A (fr) | Nouveaux derives de la cephalosporine a large spectre d'activite antibiotique | |
| BE866933A (fr) | Nouveaux derives de fortmicine | |
| PL205164A1 (pl) | Sposob wytwarzania pochodnych 2,2-dwutlenku 2,1,3-tiadiazynonu-4 | |
| BE857512A (fr) | Nouveaux derives de l'imidazole | |
| BE825075A (fr) | Nouveaux derives de la 1,2,4-oxdiazoline-5-one a activite fongicide | |
| BE851463A (fr) | Nouveaux derives d'indolizine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: GLAXO LABORATORIES LTD Effective date: 19841129 |